257 related articles for article (PubMed ID: 31184285)
1.
Rahman M; Khan MKA
J Biomol Struct Dyn; 2020 Apr; 38(7):2093-2103. PubMed ID: 31184285
[TBL] [Abstract][Full Text] [Related]
2. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
Muteeb G; Alsultan A; Farhan M; Aatif M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
[TBL] [Abstract][Full Text] [Related]
4. Identification of a potential inhibitor for New Delhi metallo-β-lactamase 1 (NDM-1) from FDA approved chemical library- a drug repurposing approach to combat carbapenem resistance.
S S; N H; Fasim A; More SS; Das Mitra S
J Biomol Struct Dyn; 2023; 41(16):7700-7711. PubMed ID: 36165602
[TBL] [Abstract][Full Text] [Related]
5. Molecular and computational approaches to understand resistance of New Delhi metallo β-lactamase variants (NDM-1, NDM-4, NDM-5, NDM-6, NDM-7)-producing strains against carbapenems.
Ali A; Gupta D; Srivastava G; Sharma A; Khan AU
J Biomol Struct Dyn; 2019 May; 37(8):2061-2071. PubMed ID: 29749296
[TBL] [Abstract][Full Text] [Related]
6. Mutations in passive residues modulate 3D-structure of NDM (New Delhi metallo-β-lactamase) protein that endue in drug resistance: a MD simulation approach.
Kumar R
J Biomol Struct Dyn; 2022; 40(19):9492-9508. PubMed ID: 34034624
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and
Moreira JS; Galvão DS; Xavier CFC; Cunha S; Pita SSDR; Reis JN; Freitas HF
J Biomol Struct Dyn; 2022; 40(24):14223-14235. PubMed ID: 34766882
[TBL] [Abstract][Full Text] [Related]
8. The Effects of One-Point Mutation on the New Delhi Metallo Beta-Lactamase-1 Resistance toward Carbapenem Antibiotics and β-Lactamase Inhibitors: An In Silico Systematic Approach.
Tran VT; Tran VH; Nguyen DN; Do TG; Vo TP; Nguyen TT; Huynh PNH; Thai KM
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555726
[TBL] [Abstract][Full Text] [Related]
9. On the Offensive: the Role of Outer Membrane Vesicles in the Successful Dissemination of New Delhi Metallo-β-lactamase (NDM-1).
Martínez MMB; Bonomo RA; Vila AJ; Maffía PC; González LJ
mBio; 2021 Oct; 12(5):e0183621. PubMed ID: 34579567
[TBL] [Abstract][Full Text] [Related]
10. A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1.
Zhu K; Lu J; Liang Z; Kong X; Ye F; Jin L; Geng H; Chen Y; Zheng M; Jiang H; Li JQ; Luo C
J Comput Aided Mol Des; 2013 Mar; 27(3):247-56. PubMed ID: 23456591
[TBL] [Abstract][Full Text] [Related]
11. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.
Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J
Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166
[TBL] [Abstract][Full Text] [Related]
12.
Vasudevan A; Kesavan DK; Wu L; Su Z; Wang S; Ramasamy MK; Hopper W; Xu H
Biomed Res Int; 2022; 2022():4230788. PubMed ID: 35372567
[TBL] [Abstract][Full Text] [Related]
13. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1).
Shen B; Yu Y; Chen H; Cao X; Lao X; Fang Y; Shi Y; Chen J; Zheng H
PLoS One; 2013; 8(5):e62955. PubMed ID: 23675445
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor and substrate binding by New Delhi metallo-beta-lactamase-1: a molecular dynamics studies.
Wang YT; Lu CY; Hour TC; Cheng TL
Curr Comput Aided Drug Des; 2014; 10(3):197-204. PubMed ID: 25479381
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Potential Inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) Using In Silico and In Vitro Approaches.
Muteeb G; Rehman MT; AlAjmi MF; Aatif M; Farhan M; Shafi S
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144666
[TBL] [Abstract][Full Text] [Related]
17. Discovery of phyto-compounds as novel inhibitors against
Kar B; Kundu CN; Pati S; Bhattacharya D
J Biomol Struct Dyn; 2023 Mar; 41(4):1267-1280. PubMed ID: 34961397
[TBL] [Abstract][Full Text] [Related]
18. Emerione A, a novel fungal metabolite as an inhibitor of New Delhi metallo-β-lactamase 1, restores carbapenem susceptibility in carbapenem-resistant isolates.
He Y; Zhou S; Sun W; Li Q; Wang J; Zhang J
J Glob Antimicrob Resist; 2022 Mar; 28():216-222. PubMed ID: 35017068
[TBL] [Abstract][Full Text] [Related]
19. Structure-based computational study of the hydrolysis of New Delhi metallo-β-lactmase-1.
Zhu K; Lu J; Ye F; Jin L; Kong X; Liang Z; Chen Y; Yu K; Jiang H; Li JQ; Luo C
Biochem Biophys Res Commun; 2013 Feb; 431(1):2-7. PubMed ID: 23313491
[TBL] [Abstract][Full Text] [Related]
20. Resistotyping, phenotyping and genotyping of New Delhi metallo-β-lactamase (NDM) among Gram-negative bacilli from Iranian patients.
Shokri D; Rabbani Khorasgani M; Fatemi SM; Soleimani-Delfan A
J Med Microbiol; 2017 Apr; 66(4):402-411. PubMed ID: 28150578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
